A class of novel N-(3S-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)-l-amino acid derivatives: their synthesis, anti-thrombotic activity evaluation, and 3D QSAR analysis-Reference-Cited by-同舟云学术

A class of novel N-(3S-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)-l-amino acid derivatives: their synthesis, anti-thrombotic activity evaluation, and 3D QSAR analysis

Published:2009-12 Issue:12 Volume:44 Page:4904-4919
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Cheng Shenling,Zhang Xiaoyi,Wang Wei,Zhao Ming,Zheng Meiqing,Chang Heng Wei,Wu Jianghui,Peng Shiqi

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference43 articles.

1. Mechanisms of platelet activation and inhibition;Ashby;Platelets Health Dis,1990

2. A macro and micro view of coronary vascular insult in ischemic heart disease;Davies;Circulation,1990

3. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina;Davies;Br. Heart. J.,1985

4. Platelet activation in unstable coronary disease;FitzGerald;N. Engl. J. Med.,1986

5. Mechanisms leading to myocardial infarction: insights from studies of vascular biology;Fuster;Circulation,1994

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An investigation of chiral diamides as organocatalysts in asymmetric aldol reaction;Journal of Heterocyclic Chemistry;2022-03-03

2. Synthesis of New Di- and Triamides as Potential Organocatalysts for Asymmetric Aldol Reaction in Water;Acta Chimica Slovenica;2020-12-15

3. Novel Synthetic Approaches for Bisnaphthalimidopropyl (BNIP) Derivatives as Potential Anti-Parasitic Agents for the Treatment of Leishmaniasis;Molecules;2019-12-16

4. Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA;International Journal of Nanomedicine;2018-02

5. Docking based design of diastereoisomeric MTCA as GPIIb/IIIa receptor inhibitor;Bioorganic & Medicinal Chemistry Letters;2017-12